Editas Medicine (EDIT) Short Interest Ratio & Short Volume

Short interest is the volume of Editas Medicine shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 15,180,000 shares of EDIT short. Learn More on Editas Medicine's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EDIT shares currently have a short interest ratio of 11.0. Learn More on Editas Medicine's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Editas Medicine: Wolverine Trading LLC, Walleye Trading LLC, Citadel Advisors LLC, Caption Management LLC, Parallax Volatility Advisers L.P., BNP Paribas Arbitrage SNC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Editas Medicine saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 15,180,000 shares, an increase of 4.7% from the previous total of 14,500,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Editas Medicine: VectivBio Holding AG (0.27%), Exscientia plc (1.98%), Allogene Therapeutics, Inc. (31.50%), Cabaletta Bio, Inc. (7.89%), Anavex Life Sciences Corp. (20.85%), 4D Molecular Therapeutics, Inc. (8.78%), Alector, Inc. (9.90%), HilleVax, Inc. (6.71%), Tarsus Pharmaceuticals, Inc. (13.46%), Ambrx Biopharma Inc. (2.09%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($8.05 billion), T-Mobile US, Inc. ($3.94 billion), Charter Communications, Inc. ($3.77 billion), Occidental Petroleum Co. ($3.27 billion), Tractor Supply ($2.29 billion), Celsius Holdings, Inc. ($2.20 billion), Rivian Automotive, Inc. ($2.10 billion), Moderna, Inc. ($2.08 billion), Royal Caribbean Cruises Ltd. ($1.90 billion), and T. Rowe Price Group, Inc. ($1.90 billion). View all of the most shorted stocks.

Short selling EDIT is an investing strategy that aims to generate trading profit from Editas Medicine as its price is falling. EDIT shares are trading down $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Editas Medicine occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EDIT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EDIT, twice per month. The most recent reporting period available is September, 15 2023.